Glypican-1 exosomes: do they initiate a new era for early pancreatic cancer diagnosis?

According to the National and Comprehensive Cancer Network (NCCN), currently pancreatic cancer (PC) is the fourth leading cause of cancer-related death among US males and females (1). Peak incidence of PC is around the 7^th–8^th decade of life, and it has been linked to few predisposing factors including: cigarette smoking, obesity, red meat and heavy alcohol consumption along with chronic pancreatitis (1).